CAS 96829-58-2
:Tetrahydrolipstatin
Description:
Tetrahydrolipstatin, also known as orlistat, is a potent lipase inhibitor primarily used in the management of obesity. It functions by inhibiting pancreatic lipase, an enzyme responsible for the breakdown of dietary fats into absorbable free fatty acids. This inhibition leads to a reduction in fat absorption from the gastrointestinal tract, promoting weight loss. Tetrahydrolipstatin is a white to off-white powder that is practically insoluble in water but soluble in organic solvents. Its molecular structure includes a lactone ring and a long fatty acid chain, contributing to its lipophilic nature. The compound is typically administered in capsule form and is often used in conjunction with a reduced-calorie diet and exercise for effective weight management. Side effects may include gastrointestinal discomfort, such as oily stools and flatulence, due to unabsorbed fats. Overall, tetrahydrolipstatin represents a unique approach to weight loss by targeting fat absorption rather than appetite suppression.
Formula:C29H53NO5
InChI:InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1
InChI key:InChIKey=AHLBNYSZXLDEJQ-FWEHEUNISA-N
SMILES:C([C@@H](OC([C@H](CC(C)C)NC=O)=O)CCCCCCCCCCC)[C@H]1[C@H](CCCCCC)C(=O)O1
Synonyms:- (-)-Tetrahydrolipstatin
- (1S)-1-{[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]methyl}dodecyl N-formyl-D-leucinate
- (S)-2-Formylamino-4-Methyl-Pentanoic Acid (S)-1-[[(2S,3S)-3-Hexyl-4-Oxo-2-Oxetanyl]Methyl]-Dodecyl Ester
- <span class="text-smallcaps">L</span>-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
- <span class="text-smallcaps">L</span>-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2α(R*),3β]]-
- Listata
- N-Formyl-L-Leucine (1S)-1-[[(2S,3S)-3-Hexyl-4-Oxo-2-Oxetanyl]Methyl]Dodecyl Ester
- Orlipastat
- Ro 18-0647/002
- Ro-18-0647
- Xenical
- [(1S)-1-[[(2S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate
- L-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2α(R*),3β]]-
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 16 products.
Orlistat
CAS:Formula:C29H53NO5Purity:>97.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:495.75Orlistat, 98%
CAS:<p>Orlistat, used in obesity research, is a pancreatic lipase inhibitor that acts locally in the gastrointestinal tract to inhibit lipase. More detailed experiments show that gradually THL affects the retinoblastoma protein pathway and leads to cell-cycle arrest at G1/S boundary. Lipase Inhibitor, THL </p>Formula:C29H53NO5Purity:98%Molecular weight:495.73Orlistat
CAS:Orlistat (Tetrahydrolipstatin) is a lipase inhibitor and a FASN inhibitor. Orlistat has been shown to promote weight loss. Cost effective and quality assured.Formula:C29H53NO5Purity:99.58% - >99.99%Color and Shape:White Crystalline PowderMolecular weight:495.73(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate
CAS:Formula:C29H53NO5Purity:98%Color and Shape:SolidMolecular weight:495.7348Ref: IN-DA0035FN
1g27.00€5g56.00€1kgTo inquire25g131.00€5kgTo inquire100g244.00€10kgTo inquire500gTo inquire100mg25.00€250mg25.00€Orlistat
CAS:Formula:C29H53NO5Purity:≥ 97.0%Color and Shape:White to almost white powder or solidMolecular weight:495.73Orlistat
CAS:Controlled Product<p>Applications Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.<br>References Borgstrom, B., et al.: Biochim. Biophys. Acta, 962, 308 (1988), Hauptman, J.B., et al.: Am. J. Clin. Nutr., 55, 309S (1992), McNeely, W., et al.: Drugs, 56, 241 (1998), Hauptman, J. B., et al.: Arch. Fam. Med., 9, 160 (2000),<br></p>Formula:C29H53NO5Color and Shape:White To Off-WhiteMolecular weight:495.73Orlistat - Bio-X ™
CAS:<p>Orlistat is a drug that has been approved for the treatment of obesity. It inhibits gastric and pancreatic lipases, which are enzymes that break down dietary fats into smaller molecules to facilitate absorption. Orlistat has been shown to reduce coronary heart disease in patients with type 2 diabetes. Orlistat has also been shown to have a significant upregulation of gene expression associated with disease activity when injected into the skin of patients with primary pulmonary hypertension.<br>Orlistat is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.</p>Formula:C29H53NO5Color and Shape:PowderMolecular weight:495.73 g/molOrlistat
CAS:<p>Lipase inhibitor; semisynthetic derivative of lipstatin</p>Formula:C29H53NO5Purity:Min. 95%Color and Shape:PowderMolecular weight:495.74 g/mol












